Prescription drug · ANDA
Gabapentin NDC 71335-0220
Gabapentin 300 mg/1 · Capsule · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-0220-0 | 71335022000 | 20 CAPSULE in 1 BOTTLE (71335-0220-0)Marketed from Apr 25, 2019 | |
| 71335-0220-1 | 71335022001 | 30 CAPSULE in 1 BOTTLE (71335-0220-1)Marketed from Mar 21, 2018 | |
| 71335-0220-2 | 71335022002 | 90 CAPSULE in 1 BOTTLE (71335-0220-2)Marketed from Mar 16, 2018 | |
| 71335-0220-3 | 71335022003 | 60 CAPSULE in 1 BOTTLE (71335-0220-3)Marketed from Mar 23, 2018 | |
| 71335-0220-4 | 71335022004 | 120 CAPSULE in 1 BOTTLE (71335-0220-4)Marketed from Mar 5, 2018 | |
| 71335-0220-5 | 71335022005 | 100 CAPSULE in 1 BOTTLE (71335-0220-5)Marketed from Mar 12, 2018 | |
| 71335-0220-6 | 71335022006 | 28 CAPSULE in 1 BOTTLE (71335-0220-6)Marketed from Oct 30, 2024 | |
| 71335-0220-7 | 71335022007 | 112 CAPSULE in 1 BOTTLE (71335-0220-7)Marketed from Oct 30, 2024 | |
| 71335-0220-8 | 71335022008 | 84 CAPSULE in 1 BOTTLE (71335-0220-8)Marketed from Apr 3, 2018 | |
| 71335-0220-9 | 71335022009 | 180 CAPSULE in 1 BOTTLE (71335-0220-9)Marketed from Feb 21, 2018 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Gabapentin
- Generic name (nonproprietary)
- gabapentin
- Active ingredients
- Gabapentin — 300 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 078428
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 71335-0220_bce0f9d7-f30d-4462-a8d3-54dd18947a8fSPL ID bce0f9d7-f30d-4462-a8d3-54dd18947a8fSPL set ID a15d5dcc-63c4-4c06-ab91-5e22cdf234ccRxCUI 310431UNII 6CW7F3G59X
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335022000followed by a unit qualifier and the quantityPackage 71335-0220-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Gabapentin capsules are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin capsules are indicated for: Postherpetic neuralgia in adults. ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 078428
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Gabapentin | Gabapentin 400 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-0820 |
| Gabapentin | Gabapentin 400 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-0214 |
| Gabapentin | Gabapentin 100 mg/1 | CapsuleOral | Unit Dose Solutions, Inc. | 87441-034 |
| Gabapentin | Gabapentin 300 mg/1 | CapsuleOral | Bryant Ranch Prepack | 72162-1813 |
| Gabapentin | Gabapentin 100 mg/1 | CapsuleOral | Amneal Pharmaceuticals of New York LLC | 53746-101 |
| Gabapentin | Gabapentin 300 mg/1 | CapsuleOral | Amneal Pharmaceuticals of New York LLC | 53746-102 |
| Gabapentin | Gabapentin 400 mg/1 | CapsuleOral | Amneal Pharmaceuticals of New York LLC | 53746-103 |
| Gabapentin | Gabapentin 300 mg/1 | CapsuleOral | Clinical Solutions Wholesale, LLC | 58118-1102 |
| Gabapentin | Gabapentin 400 mg/1 | CapsuleOral | Clinical Solutions Wholesale, LLC | 58118-1103 |
| Gabapentin | Gabapentin 100 mg/1 | CapsuleOral | Clinical Solutions Wholesale, LLC | 58118-2101 |
| Gabapentin | Gabapentin 300 mg/1 | CapsuleOral | Bryant Ranch Prepack | 63629-7306 |
| Gabapentin | Gabapentin 400 mg/1 | CapsuleOral | Amneal Pharmaceuticals LLC | 65162-103 |
| Gabapentin | Gabapentin 100 mg/1 | CapsuleOral | Amneal Pharmaceuticals LLC | 65162-101 |
| Gabapentin | Gabapentin 300 mg/1 | CapsuleOral | Amneal Pharmaceuticals LLC | 65162-102 |